Evaluation of deep learning-based deliverable VMAT plan generated by prototype software for automated planning for prostate cancer patients
Journal of Radiation Research · 2023
DOI: 10.1093/jrr/rrad058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, 2023. Verfasst von Noriyuki Kadoya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Hauptthemen laut MEDLINE: Deep Learning, Radiotherapy, Intensity-Modulated, Prostatic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
This study aims to evaluate the dosimetric accuracy of a deep learning (DL)-based deliverable volumetric arc radiation therapy (VMAT) plan generated using DL-based automated planning assistant system (AIVOT, prototype version) for patients with prostate cancer. The VMAT data (cliDose) of 68 patients with prostate cancer treated with VMAT treatment (70–74 Gy/28–37 fr) at our hospital were used (n = 55 for training and n = 13 for testing). First, a HD-U-net-based 3D dose prediction model implemented in AIVOT was customized using the VMAT data. Thus, a predictive VMAT plan (preDose) comprising AIVOT that predicted the 3D doses was generated. Second, deliverable VMAT plans (deliDose) were created using AIVOT, the radiation treatment planning system Eclipse (version 15.6) and its vender-supplied objective functions. Finally, we compared these two estimated DL-based VMAT treatment plans—i.e. preDose and deliDose—with cliDose. The average absolute dose difference of all DVH parameters for the target tissue between cliDose and deliDose across all patients was 1.32 ± 1.35% (range: 0.04–6.21%), while that for all the organs at risks was 2.08 ± 2.79% (range: 0.00–15.4%). The deliDose was superior to the cliDose in all DVH parameters for bladder and rectum. The blinded plan scoring of deliDose and cliDose was 4.54 ± 0.50 and 5.0 ± 0.0, respectively (All plans scored ≥4 points, P = 0.03.) This study demonstrated that DL-based deliverable plan for prostate cancer achieved the clinically acceptable level. Thus, the AIVOT software exhibited a potential for automated planning with no intervention for patients with prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
- Radiation Oncology Center, Ofuna Chuo Hospital, Ofuna 6-2-24, Kamakura, Kanagawa 247-0056, Japan.
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Kanokoden 1-1, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
- Department of Radiological Technology, Keio University, Shinanomachi 35, Shinjuku-ku, Tokyo 160-8582, Japan.
Zitieren
APA
Kadoya, N., Kimura, Y., Tozuka, R., Tanaka, S., Arai, K., Katsuta, Y., Shimizu, H., Sugai, Y., Yamamoto, T., Umezawa, R., & Jingu, K. (2023). Evaluation of deep learning-based deliverable VMAT plan generated by prototype software for automated planning for prostate cancer patients. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrad058
Vancouver
Kadoya N, Kimura Y, Tozuka R, Tanaka S, Arai K, Katsuta Y, et al. Evaluation of deep learning-based deliverable VMAT plan generated by prototype software for automated planning for prostate cancer patients. Journal of Radiation Research. 2023. doi:10.1093/jrr/rrad058
BibTeX
@article{Kadoya2023,
author = {Kadoya, Noriyuki and Kimura, Yuto and Tozuka, Ryota and Tanaka, Shohei and Arai, Kazuhiro and Katsuta, Yoshiyuki and Shimizu, Hidetoshi and Sugai, Yuto and Yamamoto, Takaya and Umezawa, Rei and Jingu, Keiichi},
title = {Evaluation of deep learning-based deliverable VMAT plan generated by prototype software for automated planning for prostate cancer patients},
journal = {Journal of Radiation Research},
year = {2023},
doi = {10.1093/jrr/rrad058}
}
EUVIMED